Activation of natural killer T cells by α-carba-GalCer (RCAI-56), a novel synthetic glycolipid ligand, suppresses murine collagen-induced arthritis

Clinical and Experimental Immunology

Volumn 164, Issue 2, 2011, Pages 236-247

  Yoshiga, Y ^a   Goto, D ^a   Segawa, S ^a   Horikoshi, M ^a   Hayashi, T ^a   Matsumoto, I ^a   Ito, S ^a   Taniguchi, M ^b   Sumida, T ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b RIKEN Center for Integrative Medical Sciences   (Japan)

Author keywords

Collagen induced arthritis; Glycolipid ligand; Natural killer T cells; Th1; Th17

Indexed keywords

ALPHA CARBA GALCER; ALPHA INTERFERON; COLLAGEN TYPE 2; GALACTOSYLCERAMIDE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 6; RCAI 56; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; APOPTOSIS; ARTHRITIS; ARTICLE; AUTOIMMUNE DISEASE; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE EXPRESSION; IN VIVO STUDY; MALE; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH17 CELL;

ANIMALS; ANTIBODY FORMATION; ARTHRITIS, EXPERIMENTAL; AUTOIMMUNE DISEASES; CATTLE; COLLAGEN TYPE II; DRUG EVALUATION, PRECLINICAL; GALACTOSYLCERAMIDES; IMMUNOLOGIC FACTORS; INTERFERON-GAMMA; INTERLEUKIN-23; INTERLEUKIN-6; LIGANDS; LYMPH NODES; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED DBA; NATURAL KILLER T-CELLS; SPECIFIC PATHOGEN-FREE ORGANISMS; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH17 CELLS;

EID: 79953785705     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2011.04369.x     Document Type: Article

References (50)

1. Harris ED Jr. Rheumatoid arthritis. Pathophysiology and implications for therapy. N Engl J Med 1990; 322:1277-89.
2. Luross JA, Williams NA. The genetic and immunopathological processes underlying collagen-induced arthritis. Immunology 2001; 103:407-16.
3. Ferber IA, Brocke S, Taylor-Edwards C etal. Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J Immunol 1996; 156:5-7.
4. Willenborg DO, Fordham S, Bernard CC, Cowden WB, Ramshaw IA. IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J Immunol 1996; 157:3223-7.
5. Vermeire K, Heremans H, Vandeputte M, Huang S, Billiau A, Matthys P. Accelerated collagen-induced arthritis in IFN-gamma receptor-deficient mice. J Immunol 1997; 158:5507-13.
6. Cua DJ, Sherlock J, Chen Y etal. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003; 421:744-8.
7. Murphy CA, Langrish CL, Chen Y etal. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med 2003; 198:1951-7.
8. Nakae S, Nambu A, Sudo K, Iwakura Y. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol 2003; 171:6173-7.
9. Komiyama Y, Nakae S, Matsuki T etal. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol 2006; 177:566-73.
10. Harrington LE, Hatton RD, Mangan PR etal. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005; 6:1123-32.
11. Chu CQ, Swart D, Alcorn D, Tocker J, Elkon KB. Interferon-gamma regulates susceptibility to collagen-induced arthritis through suppression of interleukin-17. Arthritis Rheum 2007; 56:1145-51.
12. Dalton DK, Haynes L, Chu CQ, Swain SL, Wittmer S. Interferon gamma eliminates responding CD4 T cells during mycobacterial infection by inducing apoptosis of activated CD4 T cells. J Exp Med 2000; 192:117-22.
13. Chu CQ, Wittmer S, Dalton DK. Failure to suppress the expansion of the activated CD4 T cell population in interferon gamma-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis. J Exp Med 2000; 192:123-8.
14. Wang Z, Hong J, Sun W etal. Role of IFN-gamma in induction of Foxp3 and conversion of CD4+ CD25- T cells to CD4+ Tregs. J Clin Invest 2006; 116:2434-41.
15. Kronenberg M, Gapin L. The unconventional lifestyle of NK T cells. Nat Rev Immunol 2002; 2:557-68.
16. Van Kaer L. alpha-Galactosylceramide therapy for autoimmune diseases: prospects and obstacles. Nat Rev Immunol 2005; 5:31-42.
17. Sumida T, Sakamoto A, Murata H etal. Selective reduction of T cells bearing invariant Vα24JαQ antigen receptor in patients with systemic sclerosis. J Exp Med 1995; 182:1163-8.
18. Sumida T, Maeda T, Taniguchi M, Nishioka K, Stohl W. TCRAV24 gene expression in double negative T cells in systemic lupus erythematosus. Lupus 1998; 7:565-8.
19. Maeda T, Keino H, Asahara H, Taniguchi M, Nishioka K, Sumida T. Decreased TCR AV24AJ18+ double negative T cells in rheumatoid synovium. Rheumatology 1999; 38:186-8.
20. Kojo S, Adachi Y, Keino H, Taniguchi M, Sumida T. Dysfunction of T cell receptor AV24AJ18+, BV11+ double-negative regulatory natural killer T cells in autoimmune diseases. Arthritis Rheum 2001; 44:1127-38.
21. Hong S, Wilson MT, Serizawa I etal. The natural killer T-cell ligand a-galactosylceramide prevents autoimmune diabetes in NOD mice. Nat Med 2001; 7:1052-6.
22. Singh AK, Wilson MT, Hong S etal. Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. J Exp Med 2001; 194:1801-11.
23. Yang JQ, Singh AK, Wilson MT etal. Immunoregulatory role of CD1d in the hydrocarbon oil-induced model of lupus nephritis. J Immunol 2003; 171:2142-53.
24. Chiba A, Kaieda S, Oki S, Yamamura T, Miyake S. The involvement of Vα14 natural killer T cells in the pathogenesis of arthritis in murine models. Arthritis Rheum 2005; 52:1941-8.
25. Ohnishi Y, Tsutsumi A, Goto D etal. TCR Valpha14 natural killer T cells function as effector T cells in mice with collagen-induced arthritis. Clin Exp Immunol 2005; 141:47-53.
26. Yoshiga Y, Goto D, Segawa S etal. Invariant NK T cells produce IL-17 through IL-23-dependent and -independent pathways with potential modulation of Th17 response in collagen-induced arthritis. Int J Mol Med 2008; 22:369-74.
27. Kim HY, Kim HJ, Min HS etal. NK T cells promote antibody-induced joint inflammation by suppressing transforming growth factor β1 production. J Exp Med 2005; 201:41-7.
28. Kim HY, Kim S, Chung DH. FcgammaRIII engagement provides activating signals to NK T cells in antibody-induced joint inflammation. J Clin Invest 2006; 116:2484-92.
29. Matsuda JL, Mallevaey T, Scott-Browne J, Gapin L. CD1d-restricted iNK T cells, the 'Swiss-Army knife' of the immune system [Review]. Curr Opin Immunol 2008; 20:358-68.
30. Miyamoto K, Miyake S, Yamamura T. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature 2001; 413:531-4.
31. Schmieg J, Yang G, Franck RW, Tsuji M. Superior protection against malaria and melanoma metastases by a C-glycoside analog of the natural killer T cell ligand alpha-galactosylceramide. J Exp Med 2003; 198:1631-41.
32. Tashiro T, Sekine-Kondo E, Shigeura T etal. Induction of Th1-biased cytokine production by alpha-carba-GalCer, a neoglycolipid ligand for NK T cells. Int Immunol 2010; 22:319-28.
33. Biburger M, Tiegs G. Activation-induced NK T cell hyporesponsiveness protects from alpha-galactosylceramide hepatitis and is independent of active transregulatory factors. J Leukoc Biol 2008; 84:264-79.
34. Cho YG, Cho ML, Min SY, Kim HY. Type II collagen autoimmunity in a mouse model of human rheumatoid arthritis. Autoimmun Rev 2007; 7:65-70.
35. Harada M, Seino K, Wakao H etal. Down-regulation of the invariant Valpha14 antigen receptor in NK T cells upon activation. Int Immunol 2004; 16:241-7.
36. Doisne JM, Becourt C, Amniai L etal. Skin and peripheral lymph node invariant NK T cells are mainly retinoic acid receptor-related orphan receptor (gamma)t+ and respond preferentially under inflammatory conditions. J Immunol 2009; 183:2142-9.
37. Bradley LM, Dalton DK, Croft M. A direct role for IFN- in regulation of Th1 cell development. J Immunol 1996; 157:1350-8.
38. Yang YF, Tomura M, Ono S, Hamaoka T, Fujiwara H. Requirement for IFN-gamma in IL-12 production induced by collaboration between v(alpha)14(+) NK T cells and antigen-presenting cells. Int Immunol 2000; 12:1669-75.
39. Sheikh SZ, Matsuoka K, Kobayashi T, Li F, Rubinas T, Plevy SE. Cutting edge: IFN-gamma is a negative regulator of IL-23 in murine macrophages and experimental colitis. J Immunol 2010; 184:4069-73.
40. Eberl G, Brawand P, MacDonald HR. Selective bystander proliferation of memory CD4+ and CD8+ T cells upon NK T or T cell activation. J Immunol 2000; 165:4305-1.
41. Seki N, Sudo Y, Yoshioka T etal. Type II collagen-induced murine arthritis: induction and perpetuation of arthritis require synergy between humoral and cell-mediated immunity. J Immunol 1998; 140:1477-84.
42. Watson WC, Townes AS. Genetic susceptibility to murine collagen II autoimmune arthritis: proposed relationship to the IgG2 autoantibody subclass response, complement C5, major histocompatibility complex (MHC), and non-MHC loci. J Exp Med 1985; 162:1878-91.
43. Snapper CM, Peçanha LM, Levine AD, Mond JJ. IgE class switching is critically dependent upon the nature of the B cell activator, in addition to the presence of IL-4. J Immunol 1991; 147:1163-70.
44. Bossie A, Vitetta ES. IFN- enhances secretion of IgG2a from IgG2a-committed LPS-stimulated murine B cells: implications for the role of IFN- in class switching. Cell Immunol 1991; 135:95-104.
45. Doreau A, Belot A, Bastid J etal. Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus. Nat Immunol 2009; 10:778-85.
46. Jacob CO, Holoshitz J, Van der Meide P, Strober S, McDevitt HO. Heterogeneous effects of IFN-gamma in adjuvant arthritis. J Immunol 1989; 142:1500-5.
47. Young HA, Hardy KJ. Role of interferon-gamma in immune cell regulation. J Leukoc Biol 1995; 58:373.
48. Miellot A, Zhu R, Diem S, Boissier MC, Herbelin A, Bessis N. Activation of invariant NK T cells protects against experimental rheumatoid arthritis by an IL-10-dependent pathway. Eur J Immunol 2005; 35:3704-13.
49. Coppieters K, Van Beneden K, Jacques P etal. A single early activation of invariant NK T cells confers long-term protection against collagen-induced arthritis in a ligand-specific manner. J Immunol 2007; 179:2300-9.
50. Hermans IF, Silk JD, Gileadi U etal. NK T cells enhance CD4+ and CD8+ T-cell responses to soluble antigen in vivo through direct interaction with dendritic cells. J Immunol 2003; 171:5140-7.